BRPI0814899A2 - Composição, vacina, metodo para amenizar um ou mais sintomas associados à infecção com o virus da influenza em um individuo e método para reduzir a probabilidade de infecção com o virus da influeza em um individuo" - Google Patents

Composição, vacina, metodo para amenizar um ou mais sintomas associados à infecção com o virus da influenza em um individuo e método para reduzir a probabilidade de infecção com o virus da influeza em um individuo"

Info

Publication number: BRPI0814899A2
Authority: BR; Brazil
Prior art keywords: individual; virus infection; vaccine; softening; probability
Prior art date: 2007-08-21

Application number

BRPI0814899-6A2A

Other languages

English (en)

Inventor

Gary Van Nest

Brian D Livingstomn

Georg Roth

Deborah A Higgins

Original Assignee

Dynavax Tech Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-08-21

Filing date

2008-08-21

Publication date

2015-02-03

2008-08-21 Application filed by Dynavax Tech Corp filed Critical Dynavax Tech Corp

2015-02-03 Publication of BRPI0814899A2 publication Critical patent/BRPI0814899A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6025—Nucleotides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Immunology (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BRPI0814899-6A2A 2007-08-21 2008-08-21 Composição, vacina, metodo para amenizar um ou mais sintomas associados à infecção com o virus da influenza em um individuo e método para reduzir a probabilidade de infecção com o virus da influeza em um individuo" BRPI0814899A2 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US95715707P	2007-08-21	2007-08-21
US8164008P	2008-07-17	2008-07-17
PCT/US2008/073921 WO2009026465A2 (en)	2007-08-21	2008-08-21	Composition and methods of making and using influenza proteins

Publications (1)

Publication Number	Publication Date
BRPI0814899A2 true BRPI0814899A2 (pt)	2015-02-03

Family

ID=40227656

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0814899-6A2A BRPI0814899A2 (pt)	2007-08-21	2008-08-21	Composição, vacina, metodo para amenizar um ou mais sintomas associados à infecção com o virus da influenza em um individuo e método para reduzir a probabilidade de infecção com o virus da influeza em um individuo"

Country Status (9)

Country	Link
US (2)	US20090196915A1 (pt)
EP (1)	EP2187961A2 (pt)
JP (1)	JP2010536878A (pt)
KR (1)	KR20100075843A (pt)
CN (1)	CN101835487A (pt)
AU (1)	AU2008288866A1 (pt)
BR (1)	BRPI0814899A2 (pt)
CA (1)	CA2697049A1 (pt)
WO (1)	WO2009026465A2 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6207646B1 (en)	1994-07-15	2001-03-27	University Of Iowa Research Foundation	Immunostimulatory nucleic acid molecules
US20030199466A1 (en)	2001-06-21	2003-10-23	Fearon Karen L.	Chimeric immunomodulatory compounds and methods of using the same - ll
EP1551376A4 (en) *	2002-08-12	2010-10-06	Dynavax Tech Corp	IMMUNOMODULATORY COMPOSITIONS, THEIR METHODS OF PREPARATION AND USE
MX2010001284A (es)	2007-08-02	2010-08-31	Biondvax Pharmaceuticals Ltd	Vacunas contra la influenza con multiepitope multimerico.
CA2771863A1 (en) *	2009-08-26	2011-03-17	Selecta Biosciences, Inc.	Compositions that induce t cell help
WO2011054995A2 (es) *	2009-11-06	2011-05-12	Chimera Pharma, S. L. U.	VACUNAS PROFILACTICAS DE GRIPE A PARTIR DE CAPSIDAS VIRALES DE BIRNAVIRUS CONTENIENDO EL ANTIGENO M2e DEL VIRUS DE LA GRIPE
CN102153654B (zh) *	2009-12-31	2012-10-10	中国疾病预防控制中心病毒病预防控制所	以免疫活性肽为载体的分支多肽及其衍生物与应用
US20130115234A1 (en) *	2010-03-26	2013-05-09	Emergent Product Development Gaithersburg,Inc.	Ectodomains of Influenza Matrix 2 Protein, Expression System, and Uses Thereof
WO2012024283A2 (en) *	2010-08-16	2012-02-23	The Wistar Institute Of Anatomy And Biology	Universal influenza a vaccines
AU2011291519A1 (en) *	2010-08-20	2013-01-24	Selecta Biosciences, Inc.	Synthetic nanocarrier vaccines comprising proteins obtained or derived from human influenza A virus hemagglutinin
US9303070B2 (en)	2011-02-22	2016-04-05	Biondvax Pharmaceuticals Ltd.	Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
CN102675410A (zh) *	2011-03-10	2012-09-19	北京中天康泰生物科技有限公司	一种分支多肽的制备方法
WO2012162342A2 (en) *	2011-05-23	2012-11-29	The Wistar Institute Of Anatomy And Biology	Influenza vaccines containing modified adenovirus vectors
CN102600466B (zh) *	2012-03-23	2014-06-11	河南农业大学	抗甲型流感病毒新型通用表位疫苗及其制备方法
CA3020873A1 (en) *	2016-04-15	2017-10-19	Dynavax Technologies Corporation	Intratumoral administration of particles containing a toll-like receptor 9 agonist and a tumor antigen for treating cancer
CN113004422B (zh) *	2021-03-04	2023-01-20	辽宁成大生物股份有限公司	一种融合蛋白、含其的疫苗及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6207646B1 (en) *	1994-07-15	2001-03-27	University Of Iowa Research Foundation	Immunostimulatory nucleic acid molecules
US6239116B1 (en) *	1994-07-15	2001-05-29	University Of Iowa Research Foundation	Immunostimulatory nucleic acid molecules
JP3468773B2 (ja) *	1994-07-15	2003-11-17	ザユニバーシティオブアイオワリサーチファウンデーション	免疫調節オリゴヌクレオチド
DE69733020T2 (de) *	1996-10-11	2006-02-16	The Regents Of The University Of California, Oakland	Immunostimulierende oligonucleotidekonjugate
US6589940B1 (en) *	1997-06-06	2003-07-08	Dynavax Technologies Corporation	Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
US20040006034A1 (en) *	1998-06-05	2004-01-08	Eyal Raz	Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
DE60041335D1 (de) *	1999-08-19	2009-02-26	Dynavax Tech Corp	Methode zur modulierung eines immunantwortes mit immunstimulierenden sequencen und zusammensetzungen dafür
US20020028784A1 (en) *	2000-03-10	2002-03-07	Nest Gary Van	Methods of preventing and treating viral infections using immunomodulatory polynucleotide sequences
US20040132677A1 (en) *	2001-06-21	2004-07-08	Fearon Karen L.	Chimeric immunomodulatory compounds and methods of using the same-IV
US20030199466A1 (en) *	2001-06-21	2003-10-23	Fearon Karen L.	Chimeric immunomodulatory compounds and methods of using the same - ll
US7785610B2 (en) *	2001-06-21	2010-08-31	Dynavax Technologies Corporation	Chimeric immunomodulatory compounds and methods of using the same—III
US7361352B2 (en) *	2001-08-15	2008-04-22	Acambis, Inc.	Influenza immunogen and vaccine
CN101693890B (zh) *	2002-12-23	2012-09-05	戴纳伐克斯技术股份有限公司	免疫刺激序列寡核苷酸和使用方法

2008
- 2008-08-21 AU AU2008288866A patent/AU2008288866A1/en not_active Abandoned
- 2008-08-21 JP JP2010522039A patent/JP2010536878A/ja active Pending
- 2008-08-21 US US12/196,015 patent/US20090196915A1/en not_active Abandoned
- 2008-08-21 KR KR1020107006064A patent/KR20100075843A/ko not_active Application Discontinuation
- 2008-08-21 CA CA2697049A patent/CA2697049A1/en not_active Abandoned
- 2008-08-21 BR BRPI0814899-6A2A patent/BRPI0814899A2/pt not_active Application Discontinuation
- 2008-08-21 WO PCT/US2008/073921 patent/WO2009026465A2/en active Application Filing
- 2008-08-21 CN CN200880112341A patent/CN101835487A/zh active Pending
- 2008-08-21 EP EP08827641A patent/EP2187961A2/en not_active Withdrawn
2012
- 2012-03-26 US US13/430,516 patent/US20130089596A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CN101835487A (zh)	2010-09-15
WO2009026465A3 (en)	2009-04-09
KR20100075843A (ko)	2010-07-05
EP2187961A2 (en)	2010-05-26
WO2009026465A2 (en)	2009-02-26
US20130089596A1 (en)	2013-04-11
AU2008288866A1 (en)	2009-02-26
CA2697049A1 (en)	2009-02-26
US20090196915A1 (en)	2009-08-06
JP2010536878A (ja)	2010-12-02

Similar Documents

Publication	Publication Date	Title
BRPI0814899A2 (pt)	2015-02-03	Composição, vacina, metodo para amenizar um ou mais sintomas associados à infecção com o virus da influenza em um individuo e método para reduzir a probabilidade de infecção com o virus da influeza em um individuo"
EP2497482A4 (en)	2013-05-01	COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF INFLUENZA AVIRUSED INDUCED DISEASES
CY1113949T1 (el)	2016-07-27	Αντιιικη συνθεση, η οποια περιεχει εναν θειικο πολυσακχαριτη: ι-καρραγενανη
BRPI1013394A2 (pt)	2016-06-21	"composto, composição farmacêutica, uso do composto, e, método para tratar um paciente infectado com virus da hepatite c."
BRPI0807597A2 (pt)	2014-05-06	Composição farmacêutica, e, método para tratar infecção por vírus da influenza
BR112014005134A2 (pt)	2017-04-18	composição farmacêutica de dissolução rápida
BRPI0913677A2 (pt)	2015-12-15	composto, metabólito purificado, método para tratar um hospedeiro infectado com um vírus flaviviridade, composição farmacêutica, método para preparar o composto purificado, e, processo para preparar o composto
BR112013005195A2 (pt)	2016-07-12	forma de dosagem resistente à violação compreendendo um polímero aniônico
BR112012030552A2 (pt)	2016-08-16	composição imunogênica
BR112015019066A2 (pt)	2017-08-22	Anticorpos humanos para proteína f do vírus respiratório sincicial e métodos de uso dos mesmos
BRPI0923448A2 (pt)	2018-10-09	vírus influenza rearranjado, composição antigênica de vírus influenza rearranjado, vacina, e, métodos para provocar uma resposta imune a pelo menos uma cepa pandêmica de vírus influenza em um indivíduo, para prevenir infecção de um indivíduo por um vírus influenza, e para preparar uma vacina.
BRPI0916235A2 (pt)	2018-03-13	composto, composição farmacêutica, uso do composto ou da composição, e, método para tratar um paciente infectado com hcv
CO6280490A2 (es)	2011-05-20	4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso
BR112012032185A2 (pt)	2016-10-11	anticorpos úteis na imunização passiva de influenza.
BR112015000685A2 (pt)	2017-11-28	método para a identificação de risco clínico em um paciente possuindo ou suspeito de possuir uma infecção por influenza, método para a identificação de influenza ou pneumonia viral em um paciente, kit, método para avaliar a eficácia de um agente para o tratamento de influenza e para reduzir a severidade da doença em um indivíduo exposto a um vírus influenza.
BR112012015202A2 (pt)	2016-04-05	"iota - e/ou kappa-carrgenado junto com um inibidor da neuraminidase, método para o tratamento profilático ou terapêutico de um sintoma, condição ou doença, composição farmacêutica,e, kit de partes".
BRPI0921424A2 (pt)	2016-01-05	vírus sincicial respiratório atenuado, composição imunogênica, molécula de ácido nucléico, célula recombinante, método para produzir uma resposta imune protetiva em um paciente, e, uso de uma quantidade imunologicamente eficaz de um ou mais dos seguintes: um rsv atenuado, uma população de rsv atenuado e uma composição imunogênica.
BRPI0809995A2 (pt)	2015-07-21	Composição, e, métodos para a liberação prolongada de um peptídeo em um paciente e para melhorar um sintoma associado com uma infecção por hiv
BR112014017141A2 (pt)	2019-09-24	método de tratamento de diabetes usando-se apolipoproteína a-iv não glicosilada
BRPI1014222A2 (pt)	2017-05-16	composto, composição farmacêutica,e, métodos para tratar distúrbio(s) cognitivo(s) ou indicações com déficit(s) na cognição, mal de alzheimer, e distúrbio bipolar
CL2015001803A1 (es)	2015-10-16	Composición inmunogénica que comprende cepas del virus del oeste del nilo muerto o inactivado o cualquier antígeno del mismo; y método para disminuir síntomas clínicos asociados a infección por dicho virus en animales (div. sol. n° 445-11)
BRPI0706871A2 (pt)	2016-08-09	uso de um extrato de sambucus nigra l., método de tratamento de uma infecção viral de influenza e método de inibição da infecção viral de influenza
BR112014003278A2 (pt)	2017-03-01	vacinas para influenza h5
BRPI0821234A2 (pt)	2015-06-16	Processo de preparação de pirocatecol purificado, e pirocatecol.
WO2009054708A3 (en)	2009-06-11	Antibody therapy for highly pathogenic avian influenza virus

Legal Events

Date	Code	Title	Description
2015-06-09	B11A	Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
2015-09-08	B11Y	Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]